Clinical diagnostics encompasses the detection, diagnosis, and monitoring of diseases and health conditions in patients. Utilizing advanced lab techniques and medical technologies, clinical scientists and healthcare professionals analyze samples such as blood, urine, and tissue to identify biomarkers, pathogens, and other indicators of illness. From point of care testing (POCT) to precision medicine approaches, clinical diagnostics plays a crucial role in early intervention, treatment planning, and disease management. Explore how this field empowers clinicians to deliver accurate diagnoses and improve patient outcomes.
Providing lab accuracy and ease of use, the HemoCue 201 System has become a standard in Glucose point-of-care testing. Allows you to accurately measure blood glucose levels to aid in the diagnosis and monitoring of diabetes.
HemoCue® Hb 201 DM System with the added benefit of data management, helping to improve workflow and safeguard patient testing data
Our trusted Glucose 201 System with built-in data management, helping you simplify your workflow and increase efficiency.
Designed for anemia screening in public health and blood donation settings, the HemoCue® Hb 301 System is an easy to use and convenient solution. The HemoCue® Hb 301 System provides quick, easy access to lab-quality results without compromising accuracy, even in demanding climates with high temperatures and humidity.
The HemoCue® Hb 801 System brings ease of use and convenience together with rigorous standards to provide you with lab-quality results at the point-of-care.
The HemoCue® Plasma/Low Hb System, you can quantitatively determine even low levels of hemoglobin in plasma, serum and aqueous solutions. With this convenient solution, you can also measure stored or banked erythrocytes.
The HemoCue® WBC System brings you the unique benefit of determining total white blood cell counts right at the point-of-care. In just three minutes, you have lab quality results.
Accumax Low Force Pipettes – the solution to your pipetting woes. Say goodbye to the pain and discomfort of traditional pipettes, and say hello to a new level of ease and precision. With our innovative design, you’ll experience reduced hand strain and fatigue, allowing you to pipette for longer periods without discomfort. Our low force technology ensures smooth and effortless operation, giving you accurate and consistent resu…
The UNIQO 160 is an all-in-one device for complete automation of indirect immunofluorescence assays (IFA) from primary sample to result proposal. The device performs all assay processing steps, as well as image acquisition and generation of result proposals using the AI-enhanced evaluation software EUROPattern Classifier. Via the EUROLabOffice 4.0 middleware, analyses with the UNIQO 160 integrate seamlessly into lab workflows.
Powered by proprietary barcoded antibody technology and leveraging an extensive database of over 350 antibodies, PhenoCycler®-Fusion 2.0 Assays make deep spatial phenotyping easier than ever. Choose from ready-to-use PhenoCode™ Discovery Panels for time-efficient studies or design your own panels to suit your specific research needs.
Opal 6-Plex Detection Kits - for Whole Slide Imaging (formerly Opal Polaris 7 Color IHC Detection Kits)
Tumors characterized as "hot" exhibit signs of inflammation, high T cell infiltration, and expression of PD-L1. These inflamed tumors typically respond well to checkpoint inhibitor immunotherapy. PhenoCode Signature Immuno-Contexture panel (CD8, CD68, PD-L1, FoxP3, PanCK) enables profiling of the tumor microenvironment for CD8+ T lymphocytes and PD-L1 expression. Map additional phenotypes by adding a 6th marker to the panel fr…
The composition of immune cells within the tumor microenvironment, such as T cells, B cells, and macrophages, varies between tumors and is strongly associated with outcomes to combination therapies. PhenoCode Signature Immune Profile panel enables profiling of the tumor microenvironment using 4 key immune cell markers (CD8, CD68, CD3e, CD20) and a tumor marker (PanCK). Map additional phenotypes by adding a 6th marker to the pa…
The ability to determine whether tumor cells are proliferating and T cells are activated could provide important information about the anti-tumor response and be an indicator of prognosis. PhenoCode Signature Activated TIL Status panel (CD8, CD3e, Ki67, Granzyme B, PanCK) enables determination of Ki67 positivity in addition to profiling of the tumor microenvironment for CD8+ T lymphocytes that are activated. Map additional phe…
Tumor associated macrophages (TAMs) play a key role in regulating the inflammatory or immunosuppressive state of the tumor microenvironemnt (TME). Distinguish between M1 (pro-inflammatory) and M2 (anti-inflammatory) TAMs using the PhenoCode™ Signature M1/M2 Polarization panel (CD8, CD68, CD163, PD-1, PD-L1) to evaluate polarization profiles in the TME. Map additional phenotypes by adding a 6th marker to the panel from the anti…
As the major population of immune cells within the tumor microenvironment (TME), T cells are a driver of anti-tumor immunity. T cell exhaustion and the presence of immunosuppressive cells can contribute to an immunosuppressive TME. PhenoCode™ Signature T Cell Status Panel (CD8, CD4, CD20, FoxP3, PD-1) allows for identification of distinct T Cell subsets and effector functionality status. Map additional phenotypes by adding a 6…
Orion Biomarkers are tailored to enable spatial biomarker analysis with maximum flexibility. Choose from a range of labeled antibodies to generate Orion spatial biology data for multiplexed tissue imaging or create new reagents with easy-to-use conjugation kits.
The stainless-steel Polaris inventory racking systems are designed for long-term sample storage applications.
Single-use virus inactivation system for batch and continuous processing.
Determination of total anti-infliximab antibodies Infliximab is a recombinant protein used to treat inflammatory bowel disease (IBD). The protein can induce humoral immune responses and lead to anti-drug antibody formation, a major cause of loss of drug response. IDKmonitor Infliximab Total Anti-drug ELISA kit is a ‘drug tolerant’ assay that enables the detection of anti-drug antibodies in the presence of circulating drug.
